1. Home
  2. RNAC

as 09-05-2025 4:00pm EST

$
-
-
.
-
-
+
$
-
.
-
-
+
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. The company leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function.

Founded: 2007 Country:
United States
United States
Employees: N/A City: FREDERICK
Market Cap: 276.3M IPO Year: 2016
Target Price: $40.00 AVG Volume (30 days): 48.0K
Analyst Decision: Strong Buy Number of Analysts: 4
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -1.49 EPS Growth: N/A
52 Week Low/High: $8.46 - $26.50 Next Earning Date: 11-06-2025
Revenue: $1,026,000 Revenue Growth: -98.10%
Revenue Growth (this year): -95.11% Revenue Growth (next year): -71.86%

RNAC Daily Stock ML Predictions

Share on Social Networks: